Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephane Bancel currently holds 6,181,970 shares of Syros Pharmaceuticals, Inc. (SYRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephane Bancel has been a net seller of SYRS stock. They have purchased $226.2K and sold $1.2B worth of shares.
Stephane Bancel's most recent insider trade was on Dec 11, 2025, when they sold 688,073 shares at $10.90 per share.
Stephane Bancel serves as Executive at Syros Pharmaceuticals, Inc. (SYRS). They have executed 1572 insider transactions totaling $1.2B over their tenure at the company.
Stephane Bancel holds the position of Executive at Syros Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Stephane Bancel has shown a selling trading pattern, with $226.2K in total purchases and $1.2B in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stephane Bancel was on Dec 11, 2025, when they sold $7.5M worth of MRNA shares. This transaction involved 688,073 shares at $10.90 per share.
Stephane Bancel currently owns 6,181,970 shares of Syros Pharmaceuticals, Inc. (SYRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephane Bancel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephane Bancel has 1572 Form 4 filings on record as an insider at Syros Pharmaceuticals, Inc..
Set alerts for Stephane Bancel and 40,000+ other insiders.